RecruitingNCT05780502

Use of an Integrated Orthotic and Rehabilitation Initiative for Treatment of Lower Extremity Musculoskeletal Disorders


Sponsor

Wake Forest University Health Sciences

Enrollment

370 participants

Start Date

May 6, 2015

Study Type

OBSERVATIONAL

Conditions

Summary

The Intrepid Dynamic Exoskeletal Orthosis (IDEO) is a custom, energy storage and return ankle orthosis proven to improve functional ability when coupled with a customized high-intensity rehabilitation program. The Return to Performance (RTP) clinical pathway is the civilian version of the evidence-based Return To Run (RTR) clinical pathway. Together, the CUSTOMIZED EXOSKELETAL ORTHOSIS and RTP form a novel orthotic and rehabilitation initiative. A diverse group of patients has utilized the pathway to date, including combat wounded Soldiers undergoing complex limb salvage procedures, those with muscle and tendon deficiencies, patients with postoperative nerve palsies, various lower extremity fractures and many others. With this study we are seeking to determine how participation in CUSTOMIZED EXOSKELETAL ORTHOSIS RTP clinical pathway affects patient outcomes as determined by validated functional outcome measures. Subjects will undergo testing before, during and after completion of the clinical pathway.


Eligibility

Min Age: 18 Years

Inclusion Criteria3

  • Minimum 18 years of age
  • Fitted with a customized exoskeletal orthosis device
  • Able to provide written informed consent

Exclusion Criteria4

  • Less than 18 years of age
  • Self-reported pregnancy
  • Not fitted with a customized exoskeletal orthosis
  • Unable or unwilling to provide written informed consent

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALPassive Dynamic Brace

Patient receiving the Passive Dynamic Brace


Locations(1)

Carolinas Medical Center

Charlotte, North Carolina, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05780502


Related Trials